Loading...
Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity
Peptide MHC class II–based (pMHCII-based) nanomedicines trigger the formation of multicellular regulatory networks by reprogramming autoantigen-experienced CD4(+) T cells into autoimmune disease–suppressing T regulatory type 1 (TR1) cells. We have shown that pMHCII-based nanomedicines displaying liv...
Na minha lista:
| Udgivet i: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108901/ https://ncbi.nlm.nih.gov/pubmed/32125290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI130670 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|